[Oncological intensive care: 2013 and 2014 years'review]
J P Sculier1, A M Bucalau1, C Closset1
1Institut Jules Bordet, Service des Soins Intensifs et Urgences Oncologiques, Centre des Tumeurs de l'Ulb, Rue Héger-Bordet 1, Bruxelles, Belgium.
Revue Medicale De Bruxelles
|May 20, 2017
Summary
This review covers 2013-2014 literature on intensive care and emergency medicine for cancer patients. It highlights advances in prognosis, life support, and managing complications like septic shock and tumor lysis syndrome.
Area of Science:
- Oncology
- Intensive Care Medicine
- Emergency Medicine
Background:
- The management of critically ill cancer patients presents unique challenges.
- Advances in oncology and critical care necessitate updated reviews.
Purpose of the Study:
- To review literature from 2013-2014 concerning intensive care and emergency medicine in oncology.
- To synthesize new findings on prognosis, life support, and oncologic emergencies.
Main Methods:
- Literature search of publications from 2013-2014.
- Focus on intensive care and emergency settings for cancer patients.
Main Results:
- New publications cover prognosis, life-supporting techniques, and septic shock.
- Anticancer treatment in intensive care, tumor lysis syndrome, and various complications (respiratory, thromboembolic, digestive, hepatic, neurologic) were discussed.
- Oncologic emergencies and therapeutic limitations were key topics.
Conclusions:
- Critical care for cancer patients involves complex management of diverse complications.
- Continuous review of literature is essential for optimizing outcomes in oncologic emergencies.
Related Concept Videos
01:19Standards of Care II
1.2K
Nurses bear specific legal responsibilities under several federal statutes, including:
1.2K
01:22Standards of Care I
1.2K
Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
1.2K
02:49Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
01:28Chronic Kidney Disease III: Interprofessional Care
544
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
544
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
565
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
565